Digital Pharma: Boehringer gets social with Facebook
September 14, 2010Medical Communications Boehringer, Digital Pharma blog, Facebook
Boehringer Ingelheim is looking for fans on Facebook and wants its employees to be thought of as “superheroes, only with …
Positive results for irritable bowel syndrome drug
September 14, 2010Research and Development Almirall, IBS, linaclotide
A new treatment for patients with irritable bowel syndrome with constipation has produced promising results in a phase III trial. …
iPhone app is download hit for Doctors.net.uk
September 14, 2010Medical Communications Doctors.net.uk, doctors, iphone, tala, tim ringrose
An app launched by Doctors.net.uk in response to a surge in the number of doctors signing up for iPhones, has …
Future of Roche diabetes trial uncertain
September 14, 2010Research and Development GLP-1, Roche, taspoglutide
Roche has admitted it does not know when phase III trials of the investigational type II diabetes drug taspoglutide will …
Growth slowdown predicted for pharma packaging
September 14, 2010Manufacturing and Production packaging, pharma packaging
New regulatory requirements in the US are driving growth in the country’s pharmaceutical packaging market, according to market research firm …
Novasep appoints new supervisory board chairman
September 14, 2010Manufacturing and Production Novasep, appointment, manufacturing and production
French contract manufacturing firm Novasep has appointed Bernard Dubois to its top management team. Most recently a consultant, Bernard formerly …
Genzyme planning 1,000 job cuts
September 14, 2010Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, job cuts
Genzyme has said it intends to cut back its workforce by around 1,000 over the next 15 months in order …
GSK launches global joint pain education programme
September 13, 2010Medical Communications chronic pain, disease awareness campaigns, osteoarthritis
GlaxoSmithKline has launched a global education programme to help sufferers from musculoskeletal conditions such as arthritis to self-manage pain in …
Zactima extends progression free survival in other thyroid cancers
September 13, 2010Research and Development thyroid cancer, zactima
New data suggests patients with the more common forms of thyroid cancer respond to AstraZeneca’s Zactima. The drug has already …
NICE won’t approve Abilify without more data
September 13, 2010Sales and Marketing Abilify, BMS, NICE
NICE is unlikely to approve Bristol-Myers Squibb’s schizophrenia drug Abilify unless the company can provide more data on its clinical …
Countdown to Launch
September 13, 2010Sales and Marketing marketing, product launch
When NASA launches a rocket, most of the hard work is already done. The flight itself is relatively short, yet …
BMS appoints UK market access director
September 13, 2010Sales and Marketing BMS, UK, appointment, sales and marketing
Patrick Hopkinson has joined Bristol-Myers Squibb as director of market access and external affairs in the UK. He joins the …
AZ signs cancer development deal
September 13, 2010Research and Development AstraZeneca, CRT, Cancer Research UK
AstraZeneca has agreed a deal with charity Cancer Research UK to develop a first-in-class cancer treatment. AZD-3965 targets the monocarboxylate …
Sanofi readies cancer drugs’ coms support
September 10, 2010Medical Communications just health pr
Sanofi-Aventis is readying communications support for two cancer drugs in its portfolio. The pharma company has handed UK communications for …
Merck plans jobs cuts in Ireland
September 10, 2010Manufacturing and Production Ireland, Merck & Co, Schering-Plough, job cuts
A manufacturing plant in Ireland is the latest to face staff cuts in the wake of Merck & Co’s merger …
Transgene acquires rights to cancer vaccine
September 10, 2010Research and Development JX-594, Jennerex, Transgene, cancer vaccine
French biotech company Transgene has acquired rights to commercialise a novel cancer vaccine that is being tested against multiple types …
Low dose Victoza on track for NICE approval
September 10, 2010Sales and Marketing NICE, Novo Nordisk, Victoza
Novo Nordisk is on track to receive NICE approval for its type II diabetes drug Victoza, but will still have …
Adventis Health adds new recruits
September 10, 2010Medical Communications Adventis, appointment, medical communications
Beaconsfield, UK-based healthcare communications agency Adventis Health has added two more recruits to its multi-disciplinary teams. Dan Blomfield (pictured left), …
GSK paves way for biopharmaceuticals growth
September 9, 2010Research and Development GlaxoSmithKline, Lonza, biologics
GlaxoSmithKline has handed Swiss contract manufacturer Lonza a contract to produce clinical trial batches of five monoclonal antibodies that are …
Universities attack European research grant
September 9, 2010Research and Development EFPIA, IMI, Innovative Medicines Initiative, academia
A European initiative aimed at fostering new medical research is neglecting its public partners in favour of its private ones, …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
